Cytoreductive (sigh-toe-ree-DUCK-tiv) surgery (CRS) is also called debulking surgery. It is a cancer surgery to reduce the number and size of cancerous tumors in the belly.
Most children who undergo this surgery have many small tumors inside the tissues lining the belly and pelvis area. This area is very close to vital organs.
The goal of CRS is to remove as much of the visible cancer as possible. CRS can be paired later with another type of treatment (usually chemotherapy) to finish killing off the remaining cancer cells.
After cancer has been debulked, it can become more vulnerable to other treatments. That means chemotherapy has a better chance of being successful and completely removing the cancer.
CRS aims to increase life expectancy by removing cancerous tumors in children with certain cancers, including:
- Desmoplastic small round cell tumors (DSRCT).
- Other cancers that have metastasized (meh-TASS-ta-sized) or spread to the tissues lining the belly.
On its own, cytoreductive surgery can:
- Increase life expectancy.
- Increase quality of life.
- Reduce cancer cells.
- Reduce the rate of tumor growth.
- Reduce symptoms.
In rare instances, this surgery alone can cure children of their cancer. But it’s usually combined with another therapy to remove microscopic cancer cells left behind after CRS.
Cytoreductive surgery for desmoplastic small round cell tumors
Desmoplastic (dez-moe-PLAZZ-tick) small round cell tumor (DSRCT) is a rare but aggressive form of childhood and young adult cancer that shows up as multiple small tumors in the belly.
Its name comes from what the cancer cells look like when studied under a microscope:
- Desmoplastic – The tumor is surrounded by fibrous tissue.
- Small round cell – The size and shape of the cancer cells are small and round.
DSRCT is caused by two specific genes – EWS and WT1 – that fuse together abnormally. This incorrect fusion creates abnormal proteins that produce cancerous cells. DSRCT usually starts in the peritoneum (pare-it-tun-NEE-um), which is the tissue that lines the belly beneath the skin.
It is common for these tiny tumors to have multiplied by the dozens or hundreds by the time a DSRCT diagnosis is made. They spread easily throughout the belly and to other vital organs, including the liver and lungs.
DSRCT has a low long-term survival rate. About 15% to 25% of children will live five years after initial diagnosis. Still, CRS can help reduce the number of tumors in the body. And, when paired with other therapies, it can often remove cancer completely.
How common are desmoplastic small round cell tumors?
DSRCT is so rare that there are currently no accurate studies on how many children are diagnosed each year.
Is cytoreductive surgery right for my child?
Cytoreductive surgery may be right for your child if they have been diagnosed with DSRCT or a similar cancer that has spread into the cavity of the belly and needs to be removed.
Your child’s care team will decide if CRS is a good option for your child. They may put together a treatment plan that includes surgery and other therapies to treat your child’s cancer.